Learn more at omadahealth.com
doi:10.1073/pnas.1215689109 21
AOD 9604 is the right peptide for someone who is already metabolically functional, who wants to address specific fat compartments, and who cannot tolerate or is not a clinical candidate for GLP-1 therapy
intra-articular PTP administration upregulates GPX4 and confers antiferroptotic and anti-inflammatory effects on chondrocytes, thereby protecting joint cartilage (174)
Clinical trials in patients with metabolic syndrome reveal that L-Carnitine supplementation of 2 g/day for extended periods (25-50 weeks) significantly reduces fasting blood glucose, HbA1c, homeostatic model assessment-insulin resistance (HOMA-IR), inflammatory markers including C-reactive protein (CRP) and tumor necrosis factor-alpha (TNF-), and triglyceride levels
I (patient name) give permission for [practice name] to give me medical treatment